Ameritas Investment Partners’s Mustang Bio MBIO Stock Holding History

Ameritas Investment Partners’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6	Closed	-$4K	–	3165
2022 Q1	$4K	Hold	6	–	–	﹤0.01%	2998
2021 Q4	$7K	Hold	6	–	–	﹤0.01%	2988
2021 Q3	$11K	Hold	6	–	–	﹤0.01%	2915
2021 Q2	$14K	Hold	6	–	–	﹤0.01%	2868
2021 Q1	$14K	Hold	6	–	–	﹤0.01%	2718
2020 Q4	$16K	Buy	6 +4	+200%	+$9.56K	﹤0.01%	2584
2020 Q3	$5K	Hold	2	–	–	﹤0.01%	2977
2020 Q2	$5K	Hold	2	–	–	﹤0.01%	2957
2020 Q1	$4K	Hold	2	–	–	﹤0.01%	2871
2019 Q4	$7K	Hold	2	–	–	﹤0.01%	2838
2019 Q3	$5K	Hold	2	–	–	﹤0.01%	2933
2019 Q2	$6K	Hold	2	–	–	﹤0.01%	2922
2019 Q1	$6K	Hold	2	–	–	﹤0.01%	2827
2018 Q4	$5K	Hold	2	–	–	﹤0.01%	2859
2018 Q3	$10K	Hold	2	–	–	﹤0.01%	2832
2018 Q2	$11K	Buy	+2	New	+$12.6K	﹤0.01%	2814

Other funds holding MBIO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Ameritas Investment Partners's MBIO Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Mustang Bio (MBIO) in Q2 2022, closing a stake of 6 shares — an estimated $4K sold.

Ameritas Investment Partners first reported a position in MBIO in Q2 2018 and held it in 16 quarters. The position peaked at $16K in Q4 2020. 71 funds tracked by Wall St. Rank hold MBIO as of Q2 2022.

Ameritas Investment Partners reported no remaining Mustang Bio position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 6 Mustang Bio shares in Q2 2022, an estimated $4K.
Ameritas Investment Partners first reported a position in Mustang Bio in Q2 2018 and held it in 16 quarters.
Ameritas Investment Partners's Mustang Bio position peaked at $16K in Q4 2020.
71 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.